Regarding Fbxo16, previous reports showed that it mediates polyubiquitination and degradation of β-catenin and heterogeneous nuclear ribonucleoprotein L (hnRNPL), both of which regulate signaling pathways leading to cell proliferation and tumor progression (46–48). The gene discussed is HNRNPL; the disease is neoplasm.